Lynda Charters

Research results can help ophthalmologists treating patients with macular edema

Investigators examine and analyze outcomes of aflibercept compared with laser treatment in patients

The use of a human monoclonal antibody (Narsoplimab, Omeros) to treat acute respiratory distress syndrome (ARDS) associated with COVID-19 resulted in recovery and survival of the affected patients.

According to a recent study, communities across the country are dealing with an increased number of mental health challenges due to “COVID-19–associated morbidity, mortality, and mitigation activities.”

Emerging technology may be able to fill existing imaging diagnostic gaps

Following cataract surgery, the dropless option is proving to be a preferred method during recovery

Researchers note that more study of conjunctivitis is needed in patients with COVID-19

Gene therapy to treat choroideremia shows potential for maintaining or improving vision

Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.

An ophthalmologist details how the COVID-19 crisis has helped him focus on essentials

Intravitreal injection offers safety, efficacy, and improved vision in patients

Reduced quality of life, mental health issues are major adverse effects of TED

For many physicians, "moral injury" may be an actual issue

An inhaled formulation of interferon beta, significantly decreased the chances of hospitalized patients developing severe COVID-19 compared to placebo.

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Researchers are looking for options to reduce corneal surface flora in patients

The COVID-19 global pandemic continues to have an impact on ophthalmologists, their practices and daily life. For patients, there can be additional pressures that are concerning.

ASRS 2020 coverage: Peter Campochiaro, MD, detailed findings of phase 2 of the Ladder Trial and ongoing Archway Trial during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

ASRS 2020 coverage: The results of the Protocol T Extension Study underscore the need for methods to improve long-term visual gains in eyes with diabetic macular edema, according to Dante Pieramici, MD,on behalf of the DRCR Retina Network.

Trabeculectomy may offer better results with more severe glaucoma

ASRS 2020 coverage: Carl Danzig, MD, presented results of phase 2 Stairway Trial during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting. Faricimab is a bispecific antibody that simultaneously inhibits angiopoietin-2 and vascular endothelial growth factor A.

Technology is off to a good start, but improvements still needed

New research is looking past just regulating the IOP, using a single-cell RNA to identify 12 distinct cell types in trabecular meshwork.

ASRS 2020 coverage: An augmented-reality device provides AMD patients with enhanced reading ability and facial recognition.

ASRS 2020 coverage: Intravitreal liposome-encapsulated bromfenac is under study as a treatment for refractory DME. Results of a pilot study were detailed at the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

ASRS 2020 coverage: The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.

Diagnostic and monitoring advances in glaucoma need fine-tuning

Columbia University researchers have successfully isolated antibodies from severely ill, ventilated patients who recovered from COVID-19.

With an eye on innovation, money is driving research of new therapies and devices.

Industry develops creative approaches to help increase patient medication adherence